ARS Pharmaceuticals (SPRY) Cash from operations

annual CFO:

$13.55M+$72.81M(+122.86%)
December 31, 2024

Summary

  • As of today (July 4, 2025), SPRY annual cash flow from operations is $13.55 million, with the most recent change of +$72.81 million (+122.86%) on December 31, 2024.
  • During the last 3 years, SPRY annual CFO has risen by +$31.11 million (+177.15%).
  • SPRY annual CFO is now at all-time high.

Performance

1-year change

+122.86%

3-year change

+177.15%

5-year change

+49.36%

15-year change

+49.36%

SPRY Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

78.54%
SPRY annual cash flow from operations is higher than 78.54% of companies in Healthcare sector

Range

All-time high

$13.55M
SPRY annual cash flow from operations is currently at an all-time high

3-year low

-$59.27M

Earnings dates

Last annual earnings report date

Dec 31, 2024
SPRY previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
SPRY next annual earnings announcement has not yet been scheduled

OtherSPRYcash flow metrics

annual CFI

-$106.10M
SPRY annual cash flow from investing activities is -$106.10 million

annual CFF

$72.40M
SPRY annual cash flow from financing activities is $72.40 million

annual FCF

$12.98M
SPRY annual free cash flow is $12.98 million

annual CAPEX

$563.00K
SPRY annual capital expenditures is $563.00 thousand

quarterly CFO:

-$40.74M-$82.75M(-197.00%)
March 31, 2025

Summary

  • As of today (July 4, 2025), SPRY quarterly cash flow from operations is -$40.74 million, with the most recent change of -$82.75 million (-197.00%) on March 31, 2025.
  • Over the past year, SPRY quarterly CFO has dropped by -$34.03 million (-507.18%).
  • SPRY quarterly CFO is now -197.00% below its all-time high of $42.00 million, reached on December 31, 2024.

Performance

3-month change

-197%

1-year change

-507.18%

3-year change

-488.33%

5-year change

-

SPRY quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

10.47%
SPRY quarterly cash flow from operations is higher than 10.47% of companies in Healthcare sector

Range

All-time high

$42.00M
SPRY quarterly cash flow from operations is currently -197.00% below its historical high of $42.00 million

3-year low

-$40.74M
SPRY quarterly cash flow from operations is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
SPRY previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 6, 2025
SPRY next earnings announcement is scheduled for Aug 6, 2025

OtherSPRYcash flow metrics

quarterly CFI

$29.06M
SPRY quarterly cash flow from investing activities is $29.06 million

quarterly CFF

$725.00K
SPRY quarterly cash flow from financing activities is $725.00 thousand

quarterly FCF

-$40.83M
SPRY quarterly free cash flow is -$40.83 million

quarterly CAPEX

$91.00K
SPRY quarterly capital expenditures is $91.00 thousand

TTM CFO:

-$20.48M-$34.03M(-251.20%)
March 31, 2025

Summary

  • As of today (July 4, 2025), SPRY TTM cash flow from operations is -$20.48 million, with the most recent change of -$34.03 million (-251.20%) on March 31, 2025.
  • Over the past year, SPRY TTM CFO has increased by +$33.06 million (+61.75%).
  • SPRY TTM CFO is now -251.20% below its all-time high of $13.55 million, reached on December 31, 2024.

Performance

3-month change

-251.2%

1-year change

+61.75%

3-year change

-195.8%

5-year change

-

SPRY TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

42.13%
SPRY TTM cash flow from operations is higher than 42.13% of companies in Healthcare sector

Range

All-time high

$13.55M
SPRY TTM cash flow from operations is currently -251.20% below its historical high of $13.55 million

3-year low

-$62.36M

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
SPRY previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Aug 6, 2025
SPRY next earnings announcement is scheduled for Aug 6, 2025

OtherSPRYcash flow metrics

TTM CFI

-$68.52M
SPRY TTM cash flow from investing activities is -$68.52 million

TTM CFF

$72.87M
SPRY TTM cash flow from financing activities is $72.87 million

TTM FCF

-$21.05M
SPRY TTM free cash flow is -$21.05 million

TTM CAPEX

$571.00K
SPRY TTM capital expenditures is $571.00 thousand

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

SPRY Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+122.9%-507.2%+61.8%
3 y3 years+177.2%-488.3%-195.8%
5 y5 years+49.4%--

SPRY Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+122.9%-197.0%at low-251.2%+67.2%
5 y5-yearat high+122.9%-197.0%at low-251.2%+67.2%
alltimeall timeat high+122.9%-197.0%at low-251.2%+67.2%

SPRY Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
-$40.74M(-197.0%)
-$20.48M(-251.2%)
Dec 2024
$13.55M(-122.9%)
$42.00M(-390.3%)
$13.55M(-129.5%)
Sep 2024
-
-$14.47M(+98.7%)
-$45.86M(+3.9%)
Jun 2024
-
-$7.28M(+8.5%)
-$44.16M(-17.5%)
Mar 2024
-
-$6.71M(-61.4%)
-$53.55M(-9.6%)
Dec 2023
-$59.27M
-$17.41M(+36.4%)
-$59.27M(-5.0%)
Sep 2023
-
-$12.76M(-23.4%)
-$62.36M(+12.8%)
DateAnnualQuarterlyTTM
Jun 2023
-
-$16.67M(+34.1%)
-$55.28M(+21.3%)
Mar 2023
-
-$12.43M(-39.4%)
-$45.58M(+13.7%)
Dec 2022
-$40.08M(+128.2%)
-$20.50M(+260.7%)
-$40.08M(+104.7%)
Sep 2022
-
-$5.68M(-18.5%)
-$19.58M(+40.9%)
Jun 2022
-
-$6.97M(+0.7%)
-$13.90M(+100.7%)
Mar 2022
-
-$6.92M
-$6.92M
Dec 2021
-$17.56M(-293.6%)
-
-
Dec 2020
$9.07M
-
-

FAQ

  • What is ARS Pharmaceuticals annual cash flow from operations?
  • What is the all time high annual CFO for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals annual CFO year-on-year change?
  • What is ARS Pharmaceuticals quarterly cash flow from operations?
  • What is the all time high quarterly CFO for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals quarterly CFO year-on-year change?
  • What is ARS Pharmaceuticals TTM cash flow from operations?
  • What is the all time high TTM CFO for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals TTM CFO year-on-year change?

What is ARS Pharmaceuticals annual cash flow from operations?

The current annual CFO of SPRY is $13.55M

What is the all time high annual CFO for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high annual cash flow from operations is $13.55M

What is ARS Pharmaceuticals annual CFO year-on-year change?

Over the past year, SPRY annual cash flow from operations has changed by +$72.81M (+122.86%)

What is ARS Pharmaceuticals quarterly cash flow from operations?

The current quarterly CFO of SPRY is -$40.74M

What is the all time high quarterly CFO for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high quarterly cash flow from operations is $42.00M

What is ARS Pharmaceuticals quarterly CFO year-on-year change?

Over the past year, SPRY quarterly cash flow from operations has changed by -$34.03M (-507.18%)

What is ARS Pharmaceuticals TTM cash flow from operations?

The current TTM CFO of SPRY is -$20.48M

What is the all time high TTM CFO for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high TTM cash flow from operations is $13.55M

What is ARS Pharmaceuticals TTM CFO year-on-year change?

Over the past year, SPRY TTM cash flow from operations has changed by +$33.06M (+61.75%)
On this page